Xiebing Bao

Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation

Jingsheng Hua, Jian Zhang, Xinyou Zhang et al. · Bone Marrow Transplantation · 2020 · 32 citations

Radiation Oncology, Cell Therapy, Transplantation +12

Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia

Qian Wang, Wenzhi Cai, Qinrong Wang et al. · American Journal of Hematology · 2022 · 26 citations

Engineering, Transcriptomic Profiling, Mixed-phenotype Acute Leukemia +20

LPCAT3 is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis

Ke Peng, Xiebing Bao, Chenxi Liu et al. · Translational Cancer Research · 2022 · 26 citations · Full text

Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients

Xiebing Bao, X-H Hu, Jian Zhuang et al. · Bone Marrow Transplantation · 2017 · 22 citations

Myelodysplastic Syndrome Patients, Hematological Malignancy, Transplantation +9

Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation

Jingsheng Hua, Jian Zhang, Xiaoxia Wu et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 22 citations

Cell Therapy, Transplantation, Marrow Transplantation +13